Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anurag Relan

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
The American Journal of Medicine|July 4, 2012
Clinical impact of peripheral attacks in hereditary angioedema patientsAndy Kusuma, Anurag Relan, André C Knulst, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 24, 2025
Clinical and genetic findings of individuals tested using the navigateAPDS genetic testing programEmily Campbell, Jenny Garkaby, Julia Upton, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 15, 2015
Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacksH Henry Li, Dumitru Moldovan, Jonathan A Bernstein, et al.
Shock (Augusta, Ga.)|July 13, 2016
C1 Inhibitor Limits Organ Injury and Prolongs Survival in Swine Subjected to Battlefield Simulated InjuryJames C Campbell, Yansong Li, Edwin van Amersfoort, et al.
The World Allergy Organization Journal|May 17, 2021
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registryAnna Valerieva, Maria T Staevska, Vesna Grivcheva-Panovska, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 18, 2019
Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in childrenAvner Reshef, Vesna Grivcheva-Panovska, Aharon Kessel, et al.
Advances in Therapy|May 2, 2026
Comparative Efficacy of Recombinant C1 Inhibitor Versus Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks: A Matching-Adjusted Indirect Treatment ComparisonJohn Anderson, Nihal Narsipur, Douglas Jones, et al.
Advances in Therapy|May 20, 2026
Post Hoc Analysis of Recombinant C1 Inhibitor Clinical Data Using Contemporary Endpoints for Hereditary AngioedemaMarc A Riedl, Nihal Narsipur, Douglas Jones, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 29, 2014
Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trialMarc A Riedl, Jonathan A Bernstein, Henry Li, et al.
Lancet (London, England)|July 30, 2017
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trialMarc A Riedl, Vesna Grivcheva-Panovska, Dumitru Moldovan, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
The American Journal of Medicine|July 4, 2012
Clinical impact of peripheral attacks in hereditary angioedema patientsAndy Kusuma, Anurag Relan, André C Knulst, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 24, 2025
Clinical and genetic findings of individuals tested using the navigateAPDS genetic testing programEmily Campbell, Jenny Garkaby, Julia Upton, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 15, 2015
Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacksH Henry Li, Dumitru Moldovan, Jonathan A Bernstein, et al.
Shock (Augusta, Ga.)|July 13, 2016
C1 Inhibitor Limits Organ Injury and Prolongs Survival in Swine Subjected to Battlefield Simulated InjuryJames C Campbell, Yansong Li, Edwin van Amersfoort, et al.
The World Allergy Organization Journal|May 17, 2021
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registryAnna Valerieva, Maria T Staevska, Vesna Grivcheva-Panovska, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 18, 2019
Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in childrenAvner Reshef, Vesna Grivcheva-Panovska, Aharon Kessel, et al.
Advances in Therapy|May 2, 2026
Comparative Efficacy of Recombinant C1 Inhibitor Versus Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks: A Matching-Adjusted Indirect Treatment ComparisonJohn Anderson, Nihal Narsipur, Douglas Jones, et al.
Advances in Therapy|May 20, 2026
Post Hoc Analysis of Recombinant C1 Inhibitor Clinical Data Using Contemporary Endpoints for Hereditary AngioedemaMarc A Riedl, Nihal Narsipur, Douglas Jones, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 29, 2014
Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trialMarc A Riedl, Jonathan A Bernstein, Henry Li, et al.
Lancet (London, England)|July 30, 2017
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trialMarc A Riedl, Vesna Grivcheva-Panovska, Dumitru Moldovan, et al.
Pageof 4